{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:33:44Z","timestamp":1794285224163,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["1UC1AI062538-01"],"award-info":[{"award-number":["1UC1AI062538-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.126","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T10:03:52Z","timestamp":1258193032000},"page":"1031-1040","source":"Crossref","is-referenced-by-count":46,"title":["Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB"],"prefix":"10.1016","volume":"28","author":[{"given":"Shannon S.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen M.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kate","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.10.126_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annu Rev Entomol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.126_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4269\/ajtmh.1979.28.329","article-title":"Ten clinical cases of human infection with Venezuelan equine encephalomyelitis virus, subtype I-D","volume":"28","author":"Dietz","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.10.126_bib3","first-page":"475","article-title":"Two human cases of laboratory infections with Mucambo virus","volume":"14","author":"de Mucha-Macias","year":"1965","journal-title":"Am J Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.126_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.126_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AEM.27.1.150-153.1974","article-title":"Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus","volume":"27","author":"Cole","year":"1974","journal-title":"Appl Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.126_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/infdis\/136.3.354","article-title":"Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine","volume":"136","author":"Burke","year":"1977","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.126_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.10.126_bib8","series-title":"Proceedings of the workshop symposium on Venezuelan encephalitis, vol. 243","first-page":"369","article-title":"Inactivated and live VEE vaccines\u2014a review","author":"McKinney RW","year":"1972"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.126_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/infdis\/140.5.708","article-title":"Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84)","volume":"140","author":"Edelman","year":"1979","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.126_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.126_bib11","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2009.10.126_bib12","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.10.126_bib13","first-page":"616","article-title":"Onset and duration of protective immunity to IA\/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice","volume":"20","author":"Hart","year":"2002","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.10.126_bib14","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.10.126_bib15","series-title":"48th ICAAC\/IDSA meeting","article-title":"Safety of an Attenuated Venezuelan equine encephalititis virus (VEEV) vaccine in humans","author":"Holley","year":"2008"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.126_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.126_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3181\/00379727-91-22215","article-title":"Inactivation of some animal viruses with gamma radiation from cobalt-60","volume":"91","author":"Jordan","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.126_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/IAI.3.4.574-579.1971","article-title":"Immunogenicity of purified Venezuelan equine encephalitis virus inactivated by ionizing radiation","volume":"3","author":"Gruber","year":"1971","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.126_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AEM.19.5.763-767.1970","article-title":"Gamma-irradiated Venezuelan equine encephalitis vaccines","volume":"19","author":"Reitman","year":"1970","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.126_bib20","series-title":"12th annual conference on vaccine research","article-title":"A multisystem approach for the evaluation of inactivation efficiency for Venezuelan equine encephalitis virus (VEEV) vaccine candidates","author":"Jenkins","year":"2009"},{"key":"10.1016\/j.vaccine.2009.10.126_bib21","series-title":"Diagnostic procedures for viral, rickettsial and chlamydial infections","first-page":"797","article-title":"Arboviruses","year":"1989"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.126_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.10.126_bib23","unstructured":"Buckley M, Hart MK. Characterization of VEE virus E2-specific monoclonal antibodies [dissertation]. Frederick, MD: Hood College; 1997."},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.126_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3181\/00379727-125-32194","article-title":"A plaque neutralization method for arboviruses","volume":"125","author":"Earley","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.126_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.10.126_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am J Physiol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.10.126_bib27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2009.10.126_bib28","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.0706296105","article-title":"Antigen kinetics determines immune reactivity","volume":"105","author":"Johansen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.10.126_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/444397","article-title":"Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques","volume":"192","author":"Reed","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.10.126_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/CDLI.12.12.1429-1436.2005","article-title":"Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51","volume":"12","author":"Sanakkayala","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.126_bib31","doi-asserted-by":"crossref","first-page":"e5336","DOI":"10.1371\/journal.pone.0005336","article-title":"Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections","volume":"4","author":"Alsharifi","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.126_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.immuni.2006.05.013","article-title":"Vaccination with irradiated Listeria induces protective T cell immunity","volume":"25","author":"Datta","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.126_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/IAI.26.1.131-136.1979","article-title":"Gamma-irradiated scrub typhus immunogens: broad-spectrum immunity with combinations of rickettsial strains","volume":"26","author":"Eisenberg","year":"1979","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.126_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0074-02762005000500016","article-title":"Resistance to reinfection in rats induced by irradiated metacercariae of Clonorchis sinensis","volume":"100","author":"Quan","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"27","key":"10.1016\/j.vaccine.2009.10.126_bib35","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.vaccine.2008.11.073","article-title":"The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine","volume":"27","author":"Chattopadhyay","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.126_bib36","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.129.6.2763","article-title":"Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies","volume":"129","author":"Mathews","year":"1982","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.126_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2009.10.126_bib38","first-page":"171","article-title":"Use of CpG DNA for enhancing specific immune responses","volume":"247","author":"Davis","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.10.126_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol Rev"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.10.126_bib40","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2009.10.126_bib41","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2005.12.034","article-title":"Enhancement of functional antibody responses to AMA1-C1\/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide","volume":"24","author":"Mullen","year":"2006","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2009.10.126_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.126_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/108729003768247628","article-title":"Safety of CpG oligodeoxynucleotides in veterinary species","volume":"13","author":"Ioannou","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.126_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00420-07","article-title":"Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques","volume":"15","author":"Stewart","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.10.126_bib45","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"issue":"31","key":"10.1016\/j.vaccine.2009.10.126_bib46","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1016\/j.vaccine.2009.04.077","article-title":"A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1\/Alhydrogel((R)) with CPG 7909, using two different formulations and dosing intervals","volume":"27","author":"Ellis","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T14:55:53Z","timestamp":1685199353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09016879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09016879"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.126","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}